MCL MMJ MANAGEMENT/TEAM HIGHLIGHTS - Asst. Prof. David

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
496
MCL MMJ MANAGEMENT/TEAM HIGHLIGHTS - Asst. Prof. David (Dedi) Meiri PhD, the TECHNION, Israel. (Timeline highlights below - click on "See More"


Dr Meiri was a guest speaker at the 2017 UIC Symposium in Melbourne. Fx Medicine's Andrew Whitfield-Cooke discusses the journey of Cannabis and the work that David and his team from the TECHNION are doing in Israel. QBL:MCL is proud to have a research partnership with the TECHNION, Israel, supporting Dr. Meiri and his team with Medical Cannabis Research.
During the interview, Dr. Meiri stated that "There is no doubt that Cannabis is making a huge change...it's a very important medicine."


TIMELINE/INTERVIEW HIGHLIGHTS
00:24 Discusses the Technion's research with Cannabis and anti-cancer research, and Cannabinoid compounds..
03:58 Discusses seasonal effects on the changing of the active compounds within the cannabis plant and how that affects the potency of Cannabis extracts.
06:23 Discusses trials with children suffering severe Epilepsy, Autism, Chron's Disease.


08:40 Discusses growing conditions and climatic effects on the potency of the plant.
09:30 Discusses the fingerprints of cannabis extracts to identify different strains to match medical conditions.
11:00 Discusses GP's use of Medical cannabis when all other medications fail.
13:18 Discusses the use of Cannabis by GP's in Israel as part of their treatment arsenal to tackle disease.
14:30 Discusses introducing Cannabis earlier in the treatment paradigm for patients with severe illness.


16:00 Discusses the whirlpool of bureaucracy between government's, politicians, regulators and GP's to get Medical Cannabis into the hands of the professionals. Dr. Meiri discusses the Database project and current clinical trials.
19:08 Discusses psychiatrists use of neuro medicines and how medical cannabis can be trialled and proved for efficacy.
20:00 Discusses the Israeli's government full support for medical Cannabis research, education and training of professionals.


22:10 Discusses how the population of Israel has changed its view on the use of medicinal cannabis. Dr. Meiri's lab is the main reference centre for all Cannabis research for the Israeli Ministry of Health.
24:00 Discusses the ignorance around medicinal cannabis education in Australia and the concerns around the lack of education and good advice.
24:50 Dr. Meiri discusses how he has 100% support for his projects by the government of Israel, the Israeli medical system, the medical fraternity and pharma companies.
https://www.youtube.com/watch?v=_C3r4Ikrh1M


Deidi Me Iri FX Medicine Interview
2017 UIC Symposium.
youtube.com

See boards updated yesterdays news.


https://www.queenslandbauxite.com/


Read More: https://investorshangout.com/post/view?id=501...z5EMZ68fh4



Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Updated Category News Views 52

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

Continue Reading
AstroRad Vest Makes Spaceflight History at Smithsonian

Updated Category News Views 58

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Continue Reading
Cooper's Stock Takes a Beating: What's Behind It?

Updated Category News Views 37

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Continue Reading
Green Methanol: A $20.11B Market by 2032 Excites

Updated Category News Views 16

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Continue Reading
Del Monte Faces Class Action Over Major Data Breach

Updated Category News Views 29

Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...

Continue Reading
Cytrellis Boosts Aesthetics Training With Miami Partnership

Updated Category News Views 35

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 60

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
SCI Faces Investigation After Earnings Downgrade

Updated Category News Views 55

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Continue Reading
Intestinal Worms: New Science and Old Challenges

Updated Category News Views 43

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
Gastops and Bell: A New Era in Aerospace Collaboration

Updated Category News Views 17

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Vitesse Energy's Q3 Performance and Future Prospects Examined

Updated Category News Views 65

Vitesse Energy's Third Quarter Highlights Vitesse Energy, Inc. (NYSE: VTS) recently shared its financial and operating results for the third quarter. The company reported a robust net income of $17.4 million alongside an adjusted net income of $7.6 million. The adjusted EBITDA reached $37.6 million, alongside operational cash flow exceeding $45.7 million, showcasing a...

Continue Reading
Capital One Financial Soars After Impressive Third-Quarter Gains

Updated Category News Views 307

Capital One's Remarkable Q3 Performance Capital One Financial Corp. (NYSE: COF) recently unveiled its third-quarter results, showcasing a strong financial performance that exceeded analysts' expectations. The report highlighted significant increases in both earnings and revenue, making a substantial impact on investor confidence and stock performance. Diving into the Key...

Continue Reading
Recent Developments Boost Travere Therapeutics' Market Outlook

Updated Category News Views 83

Update on Travere Therapeutics On a recent Wednesday, Stifel maintained its Hold rating for Travere Therapeutics (NASDAQ:TVTX) while raising the price target to $13.00 from the previous $10.00. This adjustment is a result of a thorough analysis of the company's recent progress, specifically focusing on their drug candidate, Sparsentan. Significance of the PARASOL Workshop...

Continue Reading
Kahoot! Achieves Gold Certification in Educational Equity

Updated Category News Views 106

Kahoot! Achieves Gold Certification in Educational Equity Kahoot!, the renowned education technology platform, has recently been awarded the prestigious ICEIE Gold certification for its unwavering commitment to equity in education. This recognition emphasizes the company's dedication to ensuring that all learners have access to quality educational tools and resources,...

Continue Reading
Spicewood Mineral Partners Expands Holdings with New Acquisitions

Updated Category News Views 91

Spicewood Mineral Partners Expands Holdings in the Permian Basin Spicewood Mineral Partners, a prominent mineral and energy investment firm based in Dallas, has made exciting updates regarding its latest acquisitions in the Delaware Basin. The company has recently targeted a selection of high-quality "tier 1" mineral assets in the Permian Basin, showcasing a strategic...

Continue Reading